NCT02096458View on ClinicalTrials.gov

Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Gastroesophageal Reflux DiseaseErosive EsophagitisHeartburn
Interventions
DRUG

Dexlansoprazole

Dexlansoprazole delayed-release orally disintegrating tablets

Trial Locations (1)

01801

Woburn

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY